WHITEHAWK THERAPEUTICS, INC. Net Fee Amt
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Net Fee Amt of $14.00 thousand as of 2026-05-28, per its S-3 filed 2026-05-29.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-29
- 2026-05-28: Net Fee Amt $14.00K.
| Period end | Net Fee Amt |
|---|---|
| 2026-05-28 | $14.00K S-3 · filed 2026-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |